Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b0094d1479c5b1baca382aab33284e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55301aff509cceb4fdd8f3a3ab200bde |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 |
filingDate |
2009-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4925548f7f5fe6ccaf7c1eee29bb88b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f83d736858d1475b5af5cff81d061cb |
publicationDate |
2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2011160227-A1 |
titleOfInvention |
Prolyl Hydroxylase Inhibitors |
abstract |
The invention described herein relates to certain bicyclic heteroaromatic N-substituted glycine derivatives of formula (I) n n n n n n n n n n which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10694739-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510407-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016057753-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9986733-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10065928-B2 |
priorityDate |
2008-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |